EB01 Cream 2.0% for Allergic Contact Dermatitis

"Candidates aged between 18 and 70 are viable for this trial; however, there is an additional 96 trials available to those below the age of majority, as well 156 studies appropriate for seniors above 65."

"As per clinicaltrials.gov, this particular medical trial is no longer enrolling patients; the initial listing was posted on October 15th 2019 and last updated on September 9th 2022. Nevertheless, there are 221 other trials actively searching for participants at present."

"Across the United States of America, 14 different clinical trial sites are currently in operation. Notable locations include Bexley Dermatology, The Dermatology Clinic found in Baton Rouge and Associated Skin care Specialists situated in Fridley."

"Due to the Phase 2 trial status of EB01 Cream 2.0%, our team at Power deemed its safety level as a score of two, implying that some evidence exists for its security but none yet for efficacy."

"This clinical trial is enrolling up to 126 individuals in the 18-70 age bracket who have allergic contact dermatitis. Additional requirements include: men and women of consenting age, those considered biologically able to bear children must use a reliable form contraception for at least 4 weeks pre and post study product application, surgical sterilization (hysterectomy/oophorectomy), cessation of menses for 12 months accompanied by an appropriate FSH test confirming nonchildbearing potential, male participants engaging in intercourse requiring contraceptive measures from Day 1 until 4 weeks after last study administration, negative pregnancy test for female childbearing potentials prior to screening"